{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T05:13:38Z","timestamp":1663996418230},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00108-019-0643-2","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T08:11:31Z","timestamp":1562746291000},"page":"783-791","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sklerosierende Hauterkrankungen"],"prefix":"10.1007","volume":"60","author":[{"given":"Michael","family":"Sticherling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"643_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","volume":"53","author":"C Ferreli","year":"2017","unstructured":"Ferreli\u00a0C, Gasparini\u00a0G, Parodi\u00a0A, Cozzani\u00a0E, Rongioletti\u00a0F, Atzori\u00a0L (2017) Cutaneous manifestations of scleroderma and Scleroderma-like disorders: a\u00a0comprehensive review. Clin Rev Allergy Immunol 53:306\u2013336","journal-title":"Clin Rev Allergy Immunol"},{"key":"643_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00393-018-0538-y","volume":"78","author":"ST Jendrek","year":"2019","unstructured":"Jendrek\u00a0ST, Kahle\u00a0B, Riemekasten\u00a0G (2019) Mimetics of systemic sclerosis. Z\u00a0Rheumatol 78:14\u201323","journal-title":"Z Rheumatol"},{"key":"643_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clindermatol.2018.04.004","volume":"36","author":"DR Pearson","year":"2018","unstructured":"Pearson\u00a0DR, Werth\u00a0VP, Pappas-Taffer\u00a0L (2018) Systemic sclerosis: current concepts of skin and systemic manifestations. Clin Dermatol 36:459\u2013474","journal-title":"Clin Dermatol"},{"key":"643_CR4","first-page":"783","volume":"10","author":"M Sticherling","year":"2012","unstructured":"Sticherling\u00a0M (2012) Systemic sclerosis\u2014focus on dermatological aspects. Part 2:diagnostics, therapy. J\u00a0Dtsch Dermatol Ges 10:783\u2013791","journal-title":"J Dtsch Dermatol Ges"},{"key":"643_CR5","first-page":"705","volume":"10","author":"M Sticherling","year":"2012","unstructured":"Sticherling\u00a0M (2012) Systemic sclerosis-dermatological aspects. Part 1:Pathogenesis, epidemiology, clinical findings. J\u00a0Dtsch Dermatol Ges 10:705\u2013718 (quiz 716)","journal-title":"J Dtsch Dermatol Ges"},{"key":"643_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.17219\/acem\/64334","volume":"26","author":"EJ Kucharz","year":"2017","unstructured":"Kucharz\u00a0EJ, Kope\u0107-M\u0119drek\u00a0M (2017) Systemic sclerosis sine scleroderma. Adv Clin Exp Med 26:875\u2013880","journal-title":"Adv Clin Exp Med"},{"key":"643_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jdv.14458","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler\u00a0R, Moinzadeh\u00a0P, Hunzelmann\u00a0N et al (2017) European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J\u00a0Eur Acad Dermatol Venereol 31:1401\u20131424","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"643_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask\u00a0A, Abraham\u00a0DJ (2004) TGF-beta signaling and the fibrotic response. FASEB\u00a0J 18:816\u2013827","journal-title":"FASEB J"},{"key":"643_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00281-015-0551-z","volume":"38","author":"O Distler","year":"2016","unstructured":"Distler\u00a0O, Cozzio\u00a0A (2016) Systemic sclerosis and localized scleroderma\u2014current concepts and novel targets for therapy. Semin Immunopathol 38:87\u201395","journal-title":"Semin Immunopathol"},{"key":"643_CR10","doi-asserted-by":"crossref","unstructured":"Sticherling M (2019) Systemische Sklerodermie \u2013 die dermatologische Sicht (Systemic scleroderma \u2013 the dermatological view). J Dtsch Dermatol Ges. 2019 (in press)","DOI":"10.1111\/ddg.13887_g"},{"key":"643_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.clindermatol.2018.04.008","volume":"36","author":"DM Tartar","year":"2018","unstructured":"Tartar\u00a0DM, Chung\u00a0L, Fiorentino\u00a0DF (2018) Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. Clin Dermatol 36:508\u2013524","journal-title":"Clin Dermatol"},{"key":"643_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","volume":"15","author":"ER Volkmann","year":"2019","unstructured":"Volkmann\u00a0ER, Varga\u00a0J (2019) Emerging targets of disease-modifying therapy for systemic sclerosis. Nat Rev Rheumatol 15:208\u2013224","journal-title":"Nat Rev Rheumatol"},{"key":"643_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/a-0652-2488","volume":"144","author":"G Riemekasten","year":"2019","unstructured":"Riemekasten\u00a0G (2019) Progress in systemic sclerosis\u2014early, targeted and intensive therapy is the key to success. Dtsch Med Wochenschr 144:189\u2013193","journal-title":"Dtsch Med Wochenschr"},{"key":"643_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00105-018-4258-7","volume":"69","author":"N Hunzelmann","year":"2018","unstructured":"Hunzelmann\u00a0N (2018) Current treatment of systemic scleroderma. Hautarzt 69:901\u2013907","journal-title":"Hautarzt"},{"issue":"Suppl 113","key":"643_CR15","first-page":"3","volume":"36","author":"M Orlandi","year":"2018","unstructured":"Orlandi\u00a0M, Barsotti\u00a0S, Lepri\u00a0G, Codullo\u00a0V, Di Battista\u00a0M, Guiducci\u00a0S, Rossa\u00a0DA (2018) One year in review 2018: systemic sclerosis. Clin Exp Rheumatol 36(Suppl 113):3\u201323","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 6","key":"643_CR16","first-page":"1","volume":"7","author":"A Kreuter","year":"2009","unstructured":"Kreuter\u00a0A, Krieg\u00a0T, Worm\u00a0M et\u00a0al (2009) AWMF Guideline no. 013\/066. Diagnosis and therapy of circumscribed scleroderma. J\u00a0Dtsch Dermatol Ges 7(Suppl 6):1\u201314","journal-title":"J Dtsch Dermatol Ges"},{"key":"643_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","volume":"64","author":"N Fett","year":"2011","unstructured":"Fett\u00a0N, Werth\u00a0VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J\u00a0Am Acad Dermatol 64:217\u2013228","journal-title":"J Am Acad Dermatol"},{"key":"643_CR18","first-page":"274","volume":"44","author":"K Takehara","year":"2005","unstructured":"Takehara\u00a0K, Sato\u00a0S (2005) Localized scleroderma is an autoimmune disorder. Baillieres Clin Rheumatol 44:274\u2013279","journal-title":"Baillieres Clin Rheumatol"},{"key":"643_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40257-017-0269-x","volume":"18","author":"JS Mertens","year":"2017","unstructured":"Mertens\u00a0JS, Seyger\u00a0MMB, Thurlings\u00a0RM, Radstake\u00a0TRDJ, de Jong\u00a0EMGJ (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18:491\u2013512","journal-title":"Am J Clin Dermatol"},{"key":"643_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1573397112666161007154703","volume":"13","author":"J Das","year":"2017","unstructured":"Das\u00a0J, Chinoy\u00a0H, Dick\u00a0J, Matthews\u00a0R, Roberts\u00a0M (2017) A literature review of eosinophilic fasciitis with an illustrative case. Curr Rheumatol Rev 13:113\u2013120","journal-title":"Curr Rheumatol Rev"},{"key":"643_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.03.001","author":"H Ihn","year":"2019","unstructured":"Ihn H (2019) Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int. https:\/\/doi.org\/10.1016\/j.alit.2019.03.001","journal-title":"Allergol Int"},{"key":"643_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11926-017-0700-6","volume":"19","author":"DR Mazori","year":"2017","unstructured":"Mazori\u00a0DR, Femia\u00a0AN, Vleugels\u00a0RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19:74","journal-title":"Curr Rheumatol Rep"},{"key":"643_CR23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.revmed.2015.08.002","volume":"36","author":"D S\u00e8ne","year":"2015","unstructured":"S\u00e8ne\u00a0D (2015) Eosinophilic fasciitis (Shulman\u2019s disease): diagnostic and therapeutic review. Rev Med Interne 36:738\u2013745","journal-title":"Rev Med Interne"},{"key":"643_CR24","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.14466","volume":"31","author":"R Knobler","year":"2017","unstructured":"Knobler\u00a0R, Moinzadeh\u00a0P, Hunzelmann\u00a0N, Kreuter\u00a0A, Cozzio\u00a0A, Mouthon\u00a0L, Cutolo\u00a0M, Rongioletti\u00a0F, Denton\u00a0CP, Rudnicka\u00a0L, Frasin\u00a0LA, Smith\u00a0V, Gabrielli\u00a0A, Aberer\u00a0E, Bagot\u00a0M, Bali\u00a0G, Bouaziz\u00a0J, Braae Olesen\u00a0A, Foeldvari\u00a0I, Frances\u00a0C, Jalili\u00a0A, Just\u00a0U, K\u00e4h\u00e4ri\u00a0V, K\u00e1rp\u00e1ti\u00a0S, Kofoed\u00a0K, Krasowska\u00a0D, Olszewska\u00a0M, Orteu\u00a0C, Panelius\u00a0J, Parodi\u00a0A, Petit\u00a0A, Quaglino\u00a0P, Ranki\u00a0A, Sanchez Schmidt\u00a0JM, Seneschal\u00a0J, Skrok\u00a0A, Sticherling\u00a0M, Sunderk\u00f6tter\u00a0C, Taieb\u00a0A, Tanew\u00a0A, Wolf\u00a0P, Worm\u00a0M, Wutte\u00a0NJ, Krieg\u00a0T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J\u00a0Eur Acad Dermatol Venereol 31:1581\u20131594","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"643_CR25","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00105-018-4259-6","volume":"69","author":"A Kreuter","year":"2018","unstructured":"Kreuter\u00a0A (2018) Scleredema adultorum: Clinical presentation, diagnostic workup, differential diagnosis, treatment option. Hautarzt 69:908\u2013915","journal-title":"Hautarzt"},{"key":"643_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.semarthrit.2006.01.004","volume":"35","author":"WH Beers","year":"2006","unstructured":"Beers\u00a0WH, Ince\u00a0A, Moore\u00a0TL (2006) Scleredema adultorum of Buschke: a\u00a0case report and review of the literature. Semin Arthritis Rheum 35:355\u2013359","journal-title":"Semin Arthritis Rheum"},{"key":"643_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2340\/00015555-2846","volume":"98","author":"D Miguel","year":"2018","unstructured":"Miguel\u00a0D, Schliemann\u00a0S, Elsner\u00a0P (2018) Treatment of scleroedema Adultorum Buschke: a systematic review. Acta Derm Venereol 98:305\u2013309","journal-title":"Acta Derm Venereol"},{"key":"643_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2340\/00015555-2684","volume":"97","author":"MC Kirchberger","year":"2017","unstructured":"Kirchberger\u00a0MC, Sticherling\u00a0M, Erdmann\u00a0M (2017) Uncommon presentation of scleromyxoedema with a\u00a0distribution pattern mimicking a\u00a0photodermatosis. Acta Derm Venereol 97:979\u2013980","journal-title":"Acta Derm Venereol"},{"key":"643_CR29","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00105-018-4257-8","volume":"69","author":"M Neufeld","year":"2018","unstructured":"Neufeld\u00a0M, Sunderk\u00f6tter\u00a0C, Moritz\u00a0RKC (2018) Scleromyxedema. Hautarzt 69:916\u2013921","journal-title":"Hautarzt"},{"key":"643_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00117-019-0522-9","volume":"59","author":"P Raczeck","year":"2019","unstructured":"Raczeck\u00a0P, Fries\u00a0P, B\u00fccker\u00a0A, Schneider\u00a0G (2019) Gadolinium deposition-\u201cgadolinium deposition disease\u201d. Radiologe 59:435\u2013443","journal-title":"Radiologe"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0643-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:49:24Z","timestamp":1663940964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0643-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0643-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"assertion":[{"value":"10 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Sticherling gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}